Transplantations as treatments for T1DM are generally only considered in patients who exhibit a history of hard to control diabetes, defined as ≥1 episode of severe hypoglycemia per year, frequent and severe metabolic or microvascular complications, and problems with exogenous insulin therapy [69,70,71,72]. This evidence concerns the gene INS and type 1 diabetes mellitus.